PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT

PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT

Grant-FundedCORDIS

SYNDECAN-3 BASED BLOOD TEST FOR EARLY ALZHEIMER’S DIAGNOSIS

Visit website
🇭🇺 Szeged, Hungary·pharmacoidea.eu
AI / ML · Biotech · Deep Tech
PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT is a private SME recorded in CORDIS in Hungary, with participation in 9 EU research and innovation projects. Its recorded projects include “SYNDECAN-3 BASED BLOOD TEST FOR EARLY ALZHEIMER’S DIAGNOSIS”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€3,423,113
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇭🇺Hungary
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics

Startup insights

Value proposition

PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT is a private SME recorded in CORDIS in Hungary, with participation in 9 EU research and innovation projects. Its recorded projects include “SYNDECAN-3 BASED BLOOD TEST FOR EARLY ALZHEIMER’S DIAGNOSIS”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.

AI / MLBiotechDeep Tech
Tags:AI / MLBiotechDeep Tech

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime